Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia: The OCEANS Study

By Karas Richard H.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 2, 2008-01 ,pp. : 69-81

Adis International

Access to resources Recommend Favorite

Extended-Release Niacin (Nicotinic Acid)/Laropiprant

By Perry Caroline M.  

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1665-1679

Adis International

Access to resources Recommend Favorite

Niacin Extended-Release/Simvastatin

By Sanford Mark   Curran Monique P.  

Drugs, Vol. 68, Iss. 16, 2008-01 ,pp. : 2373-2386

Adis International

Access to resources Recommend Favorite

Niacin Extended-Release Therapy in Phase III Clinical Trials is Associated with Relatively Low Rates of Drug Discontinuation due to Flushing and Treatment-Related Adverse Events: A Pooled Analysis

By Brinton Eliot A.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 179-187

Adis International

Access to resources Recommend Favorite

Niaspan: managing hyperlipidaemia with extended-release niacin

By Bradley D.  

Pharmaceutical Science & Technology Today, Vol. 3, Iss. 8, 2000-08 ,pp. : 262-263

Elsevier

Access to resources Recommend Favorite